Jinyu Bio-technology Co., Ltd. (SHA:600201)

China · Delayed Price · Currency is CNY

12.64

+0.92 (7.85%)

Jul 31, 2026, 3:00 PM CST

48.36% (1Y)

Market Cap	13.81B +45.1%
Revenue (ttm)	1.39B +10.5%
Net Income	104.27M +30.5%
EPS	0.09 +27.3%
Shares Out	1.09B
PE Ratio	136.64
Forward PE	53.47
Dividend	0.04 (0.29%)
Ex-Dividend Date	Jun 23, 2026

Volume	32,209,736
Open	11.60
Previous Close	11.72
Day's Range	11.58 - 12.78
52-Week Range	7.99 - 19.00
Beta	0.65
Analysts	Strong Buy
Price Target	14.42 (+14.08%)
Earnings Date	Aug 4, 2026

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary biological products in China and internationally. The company’s products focus on preventing porcine mycoplasmal pneumonia, pseudorabies, highly pathogenic avian influenza, brucellosis, and other Class I, II, and III animal diseases. It also provides pig vaccines, swine foot-and-mouth disease type O and A bivalent inactivated, porcine circovirus type 2 baculovirus vector inactivated, porcine reproductive and respiratory syndrome chimeric v... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1992

Employees 1,881

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600201

Full Company Profile

Financial Performance

In 2025, Jinyu Bio-technology's revenue was 1.40 billion, an increase of 11.23% compared to the previous year's 1.26 billion. Earnings were 100.11 million, a decrease of -8.14%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 600201 stock is "Strong Buy." The 12-month stock price target is ¥14.42, which is an increase of 14.08% from the latest price.

Price Target

¥14.42

(14.08% upside)

Analyst Consensus: Strong Buy

Stock Forecasts